“TECHNOLOGY FOR ENHANCING THE EFFICIENCY OF PLANT-DERIVED BIOACTIVE COMPOUNDS IN BIOLOGICAL SYSTEMS BASED ON NANOSTRUCTURED SYSTEMS AND THEIR CHEMICAL TRANSFORMATION”

Plant-derived bioactive compounds such as polyphenols, flavonoids, alkaloids, terpenoids, and phenolic acids occupy a central position in modern pharmaceutical, nutraceutical, and biomedical research. Their antioxidant, anti-inflammatory, antimicrobial, cardioprotective, and anticancer properties have been documented in numerous experimental systems. However, the practical translation of these natural molecules into effective biological interventions remains constrained by poor aqueous solubility, rapid degradation, low permeability, short circulation half-life, limited site selectivity, and variable biotransformation. The present article develops an IMRAD-structured analytical study on the technological integration of chemical transformation and nanostructured delivery systems for improving the biological efficacy of plant-derived bioactive compounds. The methodological section adopts a structured narrative review approach focused on recent literature dealing with phytochemical modification, encapsulation, controlled release, and biological performance. The results section synthesizes convergent evidence showing that rational chemical transformation, including esterification, glycosylation, methylation, complexation, prodrug design, and conjugation with lipophilic moieties, can improve molecular stability and interaction with nanocarriers, while nanostructured systems such as liposomes, nanoemulsions, polymeric nanoparticles, nanostructured lipid carriers, micelles, dendrimers, and plant-derived vesicle-like structures can enhance protection, transport, absorption, and controlled release. The discussion interprets these findings in a technological framework that links raw plant materials, extraction chemistry, molecular engineering, nanocarrier design, and biological response. Particular attention is paid to curcumin, resveratrol, quercetin, epigallocatechin gallate, berberine, and silymarin as model compounds. The article argues that the highest efficacy gains are achieved not by nanostructuring alone, but by coupling nanostructure design with molecule-level chemical transformation and process optimization. Safety, scale-up, reproducibility, regulatory standardization, and green synthesis remain critical barriers. Overall, the paper demonstrates that nano-enabled chemical transformation technologies offer a scientifically coherent route toward more stable, bioavailable, target-responsive, and biologically effective plant-derived formulations.